FLUID COMPONENT ANALYSIS SYSTEM AND METHOD FOR GLUCOSE MONITORING AND CONTROL

Patent №

US 7,972,296

Granted

2011-07-05

Filed 2008

Owner

OPTISCAN BIOMEDICAL CORPORATION

Lab

AI components

1

evo

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

12249831

Disclosed are methods and apparatus for determining analyte concentration in a sample such as bodily fluid. Systems and methods disclosed herein can also include a treatment dosing system to infuse or inject a treatment drug (e.g. insulin or glucose) and provide glycemic control. The dose of the treatment drug may be based on the concentration of the analyte or the average value for the concentration of the analyte and/or the rate of change of the value of the concentration of the analyte.

Evolutionary computationA61B 5/4839A61B 5/1427A61B 5/14532A61B 5/14535A61B 5/14546A61B 5/1455A61B 5/14557A61B 5/1495+23 more

AI classification

Evolutionary computation0.64
Knowledge representation0.09
AI hardware0.02
Natural language0.00
Planning0.00
Speech0.00
Machine learning0.00
Vision0.00

Ownership

OPTISCAN BIOMEDICAL CORPORATION

assignment · 221900016

Assignors

BRAIG, JAMES R., KEENAN, RICHARD, RULE, PETER, RIVAS, GIL, SEETHARAMAN, MAHESH

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC